BRIEF-Alnylam Pharmaceuticals names David-Alexandre Gros Principal Financial Officer
June 15, 2016 at 16:45 PM EDT
* Appointed David-Alexandre Gros, M.D. Senior VP and chief business officer to serve as principal financial officer
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.